ArticleScientific reports2025

MOF enhances the sensitivity and selectivity of sorafenib as an anticancer drug against hepatocellular carcinoma and colorectal cancer in vitro.

Emad M ElZayat et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.